首頁
RayzeBio, Inc.

7月 2026RayzeBio, Inc.的市場佔有率分析

Last updated on: June 19, 2024 If you are a participant, physician, or staff member involved in a RayzeBio clinical trial, please read the RayzeBio Privacy Notice for Clinical Trials. Privacy Summary OUR CONTACT INFORMATIONRayzeBio, Inc. Address: 5505 Morehouse Drive, Suite 300 San Diego, CA 92121 Phone number: (619) 937-2754 Email address: info@rayzebio.comContact details of our Data Protection […]

健康 > 生物技術和製藥

域名rayzebio.com

成立年份2020

僱員201 - 500

年度營收--

RayzeBio, Inc.

RayzeBio, Inc.（包含公司地區）

rayzebio.com

查看更多網站流量與參與度資訊

RayzeBio, Inc.的熱門網域總造訪量

了解RayzeBio, Inc.市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

rayzebio.com5.3K

透過銷售情報查看更多內容

RayzeBio, Inc.的熱門網域平均造訪時長

分析RayzeBio, Inc.參與度指標。

過去 3 個月平均造訪時長

子公司細目

rayzebio.com00:00:27

透過銷售情報查看更多內容

RayzeBio, Inc.的熱門網域平均頁面瀏覽量

了解RayzeBio, Inc.如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

rayzebio.com1.81

透過銷售情報查看更多內容

RayzeBio, Inc.按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術RayzeBio, Inc.

这些是RayzeBio, Inc.顶级域名使用的行业网站技术

內容管理系統 (4)

WordPress

行動裝置 (2)

Meta Viewport

小工具 (2)

Twemoji

付費廣告 (1)

PubMatic

更多技術

6

檢視所有

新聞與訊號來自RayzeBio, Inc.

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞RayzeBio, Inc. expanded facilities to Indianapolis, Indiana, United States, Northern America, Americas on Jul 1st '26.The new facility, which is expected to begin construction this year, will complement RayzeBio's current 77,000-square-foot RPT supply and manufacturing operation on the northeast side of Indianapolis, which is built to support clinical and commercial supply across the United States and worldwide.

新聞RayzeBio, Inc. had valuation of $600M on Sep 1st '24.It is worth noting that Rayzebio was most recently valued at $600M following its Series D in September of last year.

新聞RayzeBio, Inc. partnered with Philochem AG on Jun 1st '25.In June, the company, through its radiopharma subsidiary RayzeBio, partnered with Philochem to the tune of $350 million upfront and $1.35 billion in biobucks to work on prostate cancer.